Marque Bretagne

Publications

Hemarina est une société de biotechnologie qui possède une forte activité de R&D. Nos équipes possèdent un savoir faire unique, basé sur une quinzaine d'années de recherche fondamentale. Les résultats de nos travaux de recherche font l’objet de nombreux articles scientifiques publiés dans des journaux de premier plan.

Technologie Hemarina

Prof Laurent Lantieri, MD, Prof Bernard Cholley, MD, Prof Cedric Lemogne, MD, Romain Guillemain, MD, Prof Nicolas Ortonne, MD, Prof Philippe Grimbert, MD, et al
First human facial retransplantation: 30-month follow-up
The Lancet - 2020
https://www.thelancet.com/article/S0140673620324387/abstract

Tamer O.Awan, Martin Lhuaire, Laurent Lantieri; doi: 10.1097/GOX.0000000000006093.
Use of HEMHealing, an Oxygenating Dressing in the Treatment of a Full-thickness Burn on the Fingertips
last Reconstr Surg Glob Open . 2024 Aug 22; - 2024
https://journals.lww.com/prsgo/fulltext/2024/08000/use_of_hemhealing,_an_oxygenating_dressing_in_the.68.aspx

Yu He, Qiang Chang, Feng Lu
Oxygen-releasing biomaterials for chronic wounds breathing: From theoretical mechanism to application prospect
Science Direct - 2023
https://www.sciencedirect.com/science/article/pii/S2590006423001473

Tae-Hee Kim, Se-Chang Kim, Won-Kyo Jung
Therapeutic effect of marine bioactive substances against periodontitis based on in vitro, in vivo, and clinical studies
Fisheries and Aquatic Sciences - 2023
https://doi.org/10.47853/FAS.2023.e1

Batool, F., Petit, C., Stutz, C., Özçelik, H., Gegout, P. Y., Benkirane-Jessel, N., Delpy, E., Zal, F., Leize-Zal, E., Huck, O.
M101, a therapeutic oxygen carrier derived from Arenicola marina, decreased Porphyromonas gingivalis-induced hypoxia and improved periodontal healing
J Periodontol. - 2022
https://pubmed.ncbi.nlm.nih.gov/35536914/

Le Meur, Y., Delpy, E., Renard, F., Hauet, T., Badet, L., Rerolle, JP., Thierry, A., Büchler, M., Zal, F., Barrou, B.
HEMO2life® improves renal function independent of cold ischemia time in kidney recipients: A comparison with a large multicenter prospective cohort study
Artificial Organs. - 2021
https://pubmed.ncbi.nlm.nih.gov/34951495/

Asong-Fontem, N., Panisello-Rosello, A., Lopez, A., Imai, K., Zal, F., Delpy, E., Rosello-Catafau, J., Adam, R.
A Novel Oxygen Carrier (M101) Attenuates Ischemia-Reperfusion Injuries during Static Cold Storage in Steatotic Livers
Int. J. Mol. Sci. - 2021
https://pubmed.ncbi.nlm.nih.gov/34445250/

Le Daré, B., Ferron, PJ., Bellamri, N., Ribault, C., Delpy, E., Zal, F., Lagente, V., Gicquel, T.
A therapeutic oxygen carrier isolated from Arenicola marina decreases amanitin-induced hepatotoxicity
Toxicon. - 2021
https://pubmed.ncbi.nlm.nih.gov/34274377/

Batool, F., Delpy, E., Zal, F., Leize-Zal, E., Huck, O.
Therapeutic potential of hemoglobin derived from the marine worm Arenicola marina (M101): a literature review of a breakthrough innovation
Mar Drugs.  - 2021
https://pubmed.ncbi.nlm.nih.gov/34210070/

Özçelik, H., Batool, F., Corre, M., Garlaschelli, A., Conzatti, G., Stutz, C., Petit, C., Delpy, E., Zal, F., Leize-Zal, E., , Huck, O.
Characterization of a hyaluronic acid-based hydrogel containing an extracellularoxygen carrier (M101) for periodontitis treatment: an in vitro study
Int J Pharm.  - 2021
https://pubmed.ncbi.nlm.nih.gov/34144138/